Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00236977 · ClinicalTrials.gov registry record · Phase 3
Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
A Phase 3 study, sponsored by American Regent.
- Completed
- Registry status
- Phase 3
- Development phase
- 182
- Enrollment target
NCT00236977 is a Phase 3 study that has completed, run by American Regent. The registered enrollment target is 182 participants.
The verdict
NCT00236977, a Phase 3 study, has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 182 participants
- Enrollment target
Study Summary
To assess the safety and efficacy of two forms of iron therapy for the treatment of anemia in non-dialysis dependent, chronic renal failure in patients receiving or not receiving erythropoietin.
Interventions
- DRUG Ferrous Sulfate
- DRUG Venofer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00236977
The ClinicalTrials.gov registry entry for NCT00236977 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferrous Sulfate is the first listed.
NCT00236977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00236977 about?
NCT00236977 is a clinical study titled "Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia". To assess the safety and efficacy of two forms of iron therapy for the treatment of anemia in non-dialysis dependent, chronic renal failure in patients receiving or not receiving erythropoietin.
What is the current status of trial NCT00236977?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 182 participants. The study started on 2003-08. Estimated completion is 2004-10.
What interventions are being tested in trial NCT00236977?
The interventions under investigation include: Ferrous Sulfate (DRUG), Venofer (DRUG).
Who is sponsoring clinical trial NCT00236977?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.